
In a pivotal move, United States President Donald Trump has signed an executive order to withdraw the United States from the World Health Organization (WHO). This decision has sent shockwaves across the global healthcare community, with potential ramifications for health initiatives worldwide, including in India.
The US President cited multiple reasons for the withdrawal, including WHO’s handling of the COVID-19 pandemic, its perceived lack of independence from political influences, and the financial burden placed on the United States. This marks the second time the Trump administration has initiated steps to leave the global health body, following a similar attempt during his previous term.
US Funding and Global Impact
The United States has historically been the largest financial contributor to the WHO, accounting for nearly 18% of its budget. For the 2024–2025 biennium, the WHO’s budget stands at $6.8 billion, with US contributions playing a critical role in supporting programs such as immunisation, tuberculosis control, and pandemic preparedness.
The loss of US funding is likely to disrupt ongoing projects, including those combating global health challenges like HIV/AIDS and polio eradication. Additionally, the withdrawal could reduce the WHO’s ability to coordinate responses to emerging health crises and maintain its research and development initiatives.
Repercussions for India’s Healthcare Sector
India, as one of the largest recipients of WHO support, could face indirect challenges due to this decision. The WHO’s contributions to India’s healthcare landscape include technical assistance, disease surveillance, and guidance on public health policies. Key programs such as tuberculosis eradication and vaccine distribution could face delays or reduced funding if the global health body’s resources are stretched thin.
Moreover, the absence of US support might slow down collaborative efforts between Indian organizations and the WHO, potentially impacting initiatives aimed at tackling antimicrobial resistance, improving maternal and child health, and strengthening health systems.
Also Read :- MedLern and NATHEALTH Introduce Digital Health Master Class for Indian Hospitals
Industry Perspectives
The decision has sparked concerns within the healthcare industry in India. Reduced global funding could hinder innovation in areas like vaccine research and public health infrastructure. Companies reliant on international collaborations may need to reassess their strategies to mitigate the potential impact of this withdrawal.
India’s pharmaceutical industry, which plays a pivotal role in global vaccine supply, may feel the ripple effects as the WHO faces funding constraints. Additionally, the loss of US expertise and data-sharing mechanisms facilitated by the WHO could impact India’s ability to stay at the forefront of addressing global health challenges.
A Call for Resilience
As the global healthcare community navigates this development, stakeholders in India must prioritize resilience and collaboration. Strengthening domestic public health initiatives, investing in indigenous research and development, and fostering multilateral partnerships will be crucial to mitigating the fallout of reduced WHO funding.
While the US withdrawal is a significant setback, it also serves as a reminder of the need for collective action and robust local frameworks to address global health challenges effectively.
Be a part of Elets Collaborative Initiatives. Join Us for Upcoming Events and explore business opportunities. Like us on Facebook , connect with us on LinkedIn and follow us on Twitter , Instagram.